Navigation Links
Blame the environment: Why vaccines may be ineffective for some people
Date:12/1/2010

A new discovery may explain why a tuberculosis vaccine is not as effective for some people as anticipated, and potentially explains why other vaccines do not work as well for some as they do for others. In a research report presented in the December 2010 issue of the Journal of Leukocyte Biology (http://www.jleukbio.org), scientists from Singapore show that Mycobacterium chelonae, a common environmental bacterium found in soil and water, can decrease the effectiveness of the bacille Calmette-Guerin (BCG) vaccine used to prevent tuberculosis, especially in countries outside of the United States.

"Uncovering the reasons why BCG is failing will help researchers in designing new, more effective vaccines against TB," said Geok Teng Seah, Ph.D., a researcher involved in the work from the Department of Microbiology at the National University of Singapore. "This will give us more tools to fight this globally significant infectious disease."

To make this discovery, scientists studied mice with and without prior exposure to M. chelonae. When subsequently given BCG vaccine, the mice with prior exposure to M. chelonae produced higher amounts of suppressive chemical signals; these chemical signals are believed to reduce the level of immunity induced by BCG vaccine in the host mice. Then the researchers extracted certain white blood cells with known suppressive functions from both exposed and unexposed mice. After transferring these cells into separate groups of unexposed mice, they found that recipients of suppressor cells from M. chelonae exposed mice did not respond as strongly to BCG vaccine as recipients of suppressor cells from unexposed donor mice. This indicates that the suppressor cells from M. chelonae exposed mice are functionally different from those of unexposed mice. Ultimately, the data suggest that these suppressor cells, induced in the host when exposed to M. chelonae, dampen the effecti
'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Lacking Finance Education to Blame for Rising Insolvency?
2. Dont blame cities for climate change, see them as solutions
3. Discovery in legumes could reduce fertilizer use, aid environment: Stanford researchers
4. Cow vaccines go vroom
5. Scientists use computer algorithms to develop seasonal flu vaccines
6. New bacterial signaling molecule could lead to improved vaccines
7. Prescription drug could boost effects of vaccines for HIV and other diseases
8. Vaccines preventing pneumococcal disease protect African children with sickle-cell disease
9. GEN reports on the promise of DNA vaccines
10. Major breakthrough may pave the way for therapeutic vaccines
11. Bug barcode readers hold out promise of universal vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... , October 2, 2014 ... Event for payment, identification and mobility which is ... from 4 to 6 November 2014, is proud ... partnership with innovation agency FABERNOVEL.   ... this initiative is to support innovative businesses from ...
(Date:10/2/2014)... SHELTON, Conn. , Oct. 2, 2014 NXT-ID, ... focused on the growing mobile commerce market, announces the airings ... Money and Mad Money. The national ads resumed ... will air October 2 nd and October 3 rd ... The continuing ads that began airing on CNBC ...
(Date:10/2/2014)... CARTES SECURE CONNEXIONS 2014 Conference: A Step Ahead ... SECURE CONNEXIONS 2014 is being held at Paris Nord ... This 29 th  international meeting for the digital security ... together the global community of a constantly evolving sector. ... will set the pace for the event.   ...
Breaking Biology News(10 mins):CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 2CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 3CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 4CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 5CNBC Commercial Airings for Wocket Smart Wallet October 2nd and 3rd 2CNBC Commercial Airings for Wocket Smart Wallet October 2nd and 3rd 3CARTES SECURE CONNEXIONS - Conferences & Speakers 2014 2CARTES SECURE CONNEXIONS - Conferences & Speakers 2014 3CARTES SECURE CONNEXIONS - Conferences & Speakers 2014 4
... in Acta Obstetricia et Gynecologica Scandinavica , a ... and Gynecology, indicate that human error is the most ... monitoring, lack of clinical skills, and failure to obtain ... Norwegian compensation claims following birth asphyxia. In ...
... we wanted to count the number of people in a crowd, ... imprecise, or we could ask each person to pass through a ... for creating a "DNA reader" that is able to detect the ... with integrated graphene transistor. The DNA molecules are diluted in ...
... team has discovered a gene associated with a high ... may be an actual cause of this form of ... "Because asthma is a complex disease, with multiple ... asthma occurring between ages two and six," said co-lead ...
Cached Biology News:Human error most common cause of birth asphyxia 2Graphene nanoribbons for 'reading' DNA 2Novel gene variant found in severe childhood asthma 2
(Date:10/2/2014)... Livermore, California (PRWEB) October 01, 2014 ... Reyes has assumed the 2014-15 chairmanship of the ... election as vice chair in 2012. , Reyes has ... projects. She joined LLNL in 2001 to pursue her ... analysis of inertial fusion energy power plant designs. Since ...
(Date:10/2/2014)... 02, 2014 Cystic fibrosis (CF) is ... and the gastrointestinal organs. In particular, very thick mucus ... is very difficult to clear, occludes the airways, and ... these patients frequently suffer from chronic biofilm infections, and ... a novel approach to treating the major challenges in ...
(Date:10/2/2014)... (PRWEB) October 02, 2014 IAL ... fourth edition of its report on the markets ... new edition examines the developments encountered in the ... both products. , Full Report With TOC ... the market trends driving the demand. The study ...
(Date:10/2/2014)... Lexington,Kentucky and Queens, New York (PRWEB) October 02, ... is pleased to announce funding received to ... pathway in Alzheimer’s disease. A grant award from ... Institute on Aging (NIA), National Institutes of Health ... as Novel AD Therapeutics." The company also received ...
Breaking Biology Technology:Susana Reyes Assumes Chair of American Nuclear Society Fusion Energy Division 2Synedgen to Present at North American Cystic Fibrosis Conference 2Synedgen to Present at North American Cystic Fibrosis Conference 3Global Overview of the Spray Polyurethane Foam (SPF) & One Component Foam (OCF) : Industry Analysis, Size, Share, Trends And Forecast Research Report by Researchmoz 2Gismo Therapeutics Inc. Awarded Grants to Develop New Alzheimer's Disease Therapeutics 2Gismo Therapeutics Inc. Awarded Grants to Develop New Alzheimer's Disease Therapeutics 3
... 2011 NewCardio, Inc., (OTC BB: NWCI) a cardiovascular ... Clinilabs, will utilize QTinno®, NewCardio,s automated cardiac safety solution, ... new drug under development for a central nervous system ... one important aspect of the trial. Clinilabs, ...
... a biotechnology company developing peptide therapeutics for metabolic diseases, ... as Chief Executive Officer. Dr. Gottesdiener joins Rhythm from ... President and Late-Stage Therapeutic Group Leader, with responsibility for ... and previously as head of early-stage clinical development programs. ...
... -- an open-source, web-based platform for data-intensive biomedical ... a "cloud computing" resource. A team of researchers ... and molecular biology at Penn State University; Kateryna ... State; and James Taylor from Emory University, developed ...
Cached Biology Technology:Clinilabs will Conduct Phase 1 Trial Using QTinno® 2Clinilabs will Conduct Phase 1 Trial Using QTinno® 3Clinilabs will Conduct Phase 1 Trial Using QTinno® 4Clinilabs will Conduct Phase 1 Trial Using QTinno® 5Rhythm Names Keith M. Gottesdiener Chief Executive Officer 2Galaxy DNA-analysis software is now available 'in the cloud' 2Galaxy DNA-analysis software is now available 'in the cloud' 3
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Reactivity: Human...
2-min, single-step add-mix-measure assay for luciferase expression and HTS in mammalian cells. Linear detection range: 2 fg to 46 ng luciferase....
Endomorphin-2. Cross reactivity: Endomorphin-1 3%, Met-enkephalin <0.03%, Leu-enkephalin <0.01% and beta-Endorphin <0.01%....
Biology Products: